Remote Monitoring and Symptom Management Digital Application
Pilot Randomized Controlled Trial of a Remote Monitoring and Symptom Management Intervention (ASSIST) Among Patients Receiving Systemic Therapy
Patrick C. Johnson, MD
60 participants
Apr 14, 2026
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to learn if an artificial intelligence phone application called ASSIST can help patients receiving cancer treatment. The main question\[s\] it aims to answer are: Is ASSIST feasible for patients (meaning can it be used by patients)? Is ASSIST acceptable to patients (meaning do patients like it)? Researchers will compare the ASSIST phone application to see how it compares to usual clinical care. Participants on the ASSIST arm will use the ASSIST phone application for 12 weeks, and participants in both groups will complete surveys.
Eligibility
Inclusion Criteria5
- Age 18 years or older
- Ability to understand English
- About to begin definitive systemic treatment (or within 4 weeks of beginning treatment) based upon the oncology treatment intent form for a new diagnosis of breast cancer, colorectal cancer, or lymphoma.
- Expected treatment duration of at least 12 weeks
- Own or willing to receive a smartphone
Exclusion Criteria3
- Cognitive impairment that would interfere with ability to use smartphone application (as assessed by their attending physician)
- Visual or motor impairment that would prevent smartphone use
- Expected survival less than 3 months
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The intervention consists of a smartphone-based application that provides personalized support using AI during cancer treatment. Patients will also receive standard care from their oncology team, including routine symptom management and supportive care measures.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07553572